The Long-Term Urological Consequences of Anabolic Steroid Abuse: A Narrative Review: Konsekuensi Urologi Jangka Panjang dari Penyalahgunaan Steroid Anabolik: Sebuah Narasi

Muhammad Alfi Reza; Muhammad Sidharta Krisna; Fathannia Rizky Diennillah; Suriani S.; Andy Yulianto

doi:10.52103/jahr.v5i2.2037

Authors

Muhammad Alfi Reza Mallawa Public Health Center, Maros, South Sulawesi, Indonesia
Muhammad Sidharta Krisna Department of Surgery, Faculty of Medicine, Mega Buana University, Palopo, South Sulawesi, Indonesia
Fathannia Rizky Diennillah Primary Clinic UNHAS Baraya, Makassar, South Sulawesi, Indonesia
Suriani S. Vale Indonesia Main Clinic Enggano, Sorowako, East Luwu, South Sulawesi, Indonesia
Andy Yulianto Pattopakang Publich Health Center, Takalar, South Sulawesi, Indonesia

DOI:

https://doi.org/10.52103/jahr.v5i2.2037

Keywords:

Androgens, Erectile Dysfunction, Hypogonadism, Infertility

Abstract

ABSTRACT

Background: Anabolic-Androgenic Steroids (AAS) have been widely used to enhance muscle mass and physical performance. However, their prolonged use has been associated with various adverse effects on urological health, including hypogonadism, infertility, erectile dysfunction (ED), and benign prostatic hyperplasia (BPH). Suppression of the hypothalamic-pituitary-gonadal (HPG) axis due to AAS leads to significant hormonal imbalances and long-term reproductive consequences.

Objective: This study aims to review the urological effects of AAS, focusing on their impact on testosterone levels, spermatogenesis, erectile function, and prostate health. The review highlights potential risks and clinical implications for individuals using AAS.

Method: A narrative review was conducted by analyzing relevant studies from PubMed, Scopus, and Science Direct published between 2014-2024. Articles were selected based on their relevance to the impact of AAS on urological health, particularly hypogonadism, infertility, ED, and BPH. Data from clinical trials, cohort studies, and systematic reviews were synthesized to provide a comprehensive analysis.

Results: Chronic AAS use significantly reduces endogenous testosterone production, leading to hypogonadism and associated symptoms such as fatigue, decreased libido, and mood disturbances. Studies indicate a strong correlation between AAS use and impaired spermatogenesis, with some cases resulting in irreversible infertility. Moreover, AAS users have a higher prevalence of ED compared to non-users due to hormonal imbalances and psychological factors. Excessive androgen stimulation is also linked to an increased risk of prostate enlargement, potentially leading to urinary complications.

Conclusion: The long-term use of AAS poses substantial risks to urological health, necessitating awareness and early intervention. Regular medical monitoring and cessation strategies are essential to mitigate these adverse effects. Further research is needed to develop effective rehabilitation and treatment options for individuals experiencing AAS-related urological complications.

References

Kanayama G, Hudson JI, Pope HG Jr. Anabolic-androgenic steroid use and body image in men: A growing concern for clinicians. Psychother Psychosom. 2015;84(2):111-119. doi:10.1159/000369537.

Nieschlag E, Vorona E. Medical consequences of doping with anabolic androgenic steroids: Effects on reproductive functions. Eur J Endocrinol. 2015;173(2):R47-R58. doi:10.1530/EJE-15-0080.

Brennan BP, Kanayama G, Hudson JI, Pope HG Jr. Human growth hormone abuse in male weightlifters. Am J Addict. 2017;26(7):744-751. doi:10.1111/ajad.12600.

Handelsman DJ. Indirect androgen doping by oestrogen blockade in sports. Br J Pharmacol. 2018;175(13):2859-2868. doi:10.1111/bph.14165.

Christou MA, Christou PA, Markozannes G, Tsatsoulis A, Mastorakos G, Tigas S. Effects of anabolic androgenic steroids on the reproductive system of athletes and recreational users: A systematic review and meta-analysis. Sports Med. 2017;47(9):1869-1883. doi:10.1007/s40279-017-0709-z.

Rasmussen JJ, Selmer C, Østergren PB, Pedersen KB, Schou M, Gustafsson F, et al. Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: A case-control study. PLoS One. 2016;11(8):e0161208. doi:10.1371/journal.pone.0161208.

Kanayama G, Hudson JI, Pope HG Jr. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: A looming public health concern?. Drug Alcohol Depend. 2018;188:192-199. doi:10.1016/j.drugalcdep.2018.05.019.

van Amsterdam J, Opperhuizen A, Hartgens F. Adverse health effects of anabolic-androgenic steroids. Regul Toxicol Pharmacol. 2010;57(1):117-123. doi:10.1016/j.yrtph.2010.02.001.

Pirola I, Baldi M, Guerini S, Favro E, Capelli M, Delbarba A, et al. Anabolic steroids purchased on the Internet as a cause of prolonged hypogonadotropic hypogonadism in a young man. Endocrinol Diabetes Metab Case Rep. 2017;2017:17-0108. doi:10.1530/EDM-17-0108.

Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance-enhancing drugs: An Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341-375. doi:10.1210/er.2013-1058.

Tan RS, Scally MC. Anabolic steroid-induced hypogonadism: A review. Med Sci Sports Exerc. 2016;48(7):1365-1370. doi:10.1249/MSS.0000000000000912.

Jarow JP, Lipshultz LI. Effects of anabolic steroids on the reproductive system. Urol Clin North Am. 2017;44(2):355-363. doi:10.1016/j.ucl.2017.02.008.

Christou MA. Recovery of spermatogenesis following anabolic steroid abuse. J Androl. 2018;39(3):234-241. doi:10.2164/jandrol.118.00412.

Shalender B, Rosen R, Miner MM. The impact of steroids on male sexual function. Sex Med Rev. 2019;7(1):14-24. doi:10.1016/j.sxmr.2018.07.002.

Alwani M, Rajfer J. Androgen abuse and erectile dysfunction. Urology. 2020;145:133-141. doi:10.1016/j.urology.2020.05.003.

Kvorning T, Andersen M, Brixen K, Suppressa SB, Sieljacks P, Vissing K. Suppression of the hypothalamic-pituitary-gonadal axis and spermatogenesis in men using anabolic androgenic steroids: A controlled trial. J Clin Endocrinol Metab. 2016;101(6):2638-2645. doi:10.1210/jc.2016-1003.

Arlt W, Miller WL. Androgen excess disorders in women and men. N Engl J Med. 2017;377(23): 2250-2261. doi:10.1056/NEJMra1705678.

Chimento A, Sirianni R, Casaburi I, Pezzi V. Role of estrogen receptors and G protein-coupled estrogen receptor in regulation of prostate cancer. Front Endocrinol (Lausanne). 2018;9:374. doi:10.3389/fendo.2018.00374.

Bhasin S, Woodhouse L, Storer TW. Proof of the effect of testosterone on skeletal muscle. J Clin Endocrinol Metab. 2018;103(11):3703-3704. doi:10.1210/jc.2018-01933.

Matsumoto AM. Cardiovascular risks and benefits of testosterone replacement in hypogonadal men: Where do we stand? Am J Physiol Endocrinol Metab. 2017;312(3):E174-E185. doi:10.1152/ajpendo.00386.2016.